Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Dual Roles of NRF2 in Cancer
Silvia Menegon, Amedeo Columbano, Silvia Giordano
Trends in Molecular Medicine (2016) Vol. 22, Iss. 7, pp. 578-593
Open Access | Times Cited: 566

Showing 1-25 of 566 citing articles:

ROS in cancer therapy: the bright side of the moon
Bruno Perillo, Marzia Di Donato, Antonio Pezone, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 2, pp. 192-203
Open Access | Times Cited: 1726
Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach
Christophe Glorieux, Pedro Buc Calderón
Biological Chemistry (2017) Vol. 398, Iss. 10, pp. 1095-1108
Open Access | Times Cited: 534
The KEAP1–NRF2 System in Cancer
Keiko Taguchi, Masayuki Yamamoto
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 444
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Li Zuo, Evan R. Prather, Mykola Stetskiv, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4472-4472
Open Access | Times Cited: 405
Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer
Nikos Koundouros, George Poulogiannis
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 356
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Justine Habault, Jean‐Luc Poyet
Molecules (2019) Vol. 24, Iss. 5, pp. 927-927
Open Access | Times Cited: 261
The Role of Nrf2 Activity in Cancer Development and Progression
Alina‐Andreea Zimța, Diana Cenariu, Alexandru Irimie, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1755-1755
Open Access | Times Cited: 228
Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
Dharambir Kashyap, Vivek Kumar Garg, Hardeep Singh Tuli, et al.
Biomolecules (2019) Vol. 9, Iss. 5, pp. 174-174
Open Access | Times Cited: 218
Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment
Sarah A. Best, David P. De Souza, Ariena Kersbergen, et al.
Cell Metabolism (2018) Vol. 27, Iss. 4, pp. 935-943.e4
Open Access | Times Cited: 193
NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer
Kuojun Zhang, Chen Dong, Kun Ma, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 16, pp. 6983-7003
Closed Access | Times Cited: 191
Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours
Sonia Missiroli, Mariasole Perrone, Ilaria Genovese, et al.
EBioMedicine (2020) Vol. 59, pp. 102943-102943
Open Access | Times Cited: 188
Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment
Maria Russo, Carmela Spagnuolo, Gian Luigi Russo, et al.
Critical Reviews in Food Science and Nutrition (2016) Vol. 58, Iss. 8, pp. 1391-1405
Closed Access | Times Cited: 172
Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance
Azhwar Raghunath, Kiruthika Sundarraj, Frank Arfuso, et al.
Cancers (2018) Vol. 10, Iss. 12, pp. 481-481
Open Access | Times Cited: 166
Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function
Xiaozhen Dai, Xiaoqing Yan, Kupper A. Wintergerst, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 2, pp. 185-200
Open Access | Times Cited: 165
Recent Advances of Natural Polyphenols Activators for Keap1‐Nrf2 Signaling Pathway
Yanping Zhou, Zhongliang Jiang, Haiying Lu, et al.
Chemistry & Biodiversity (2019) Vol. 16, Iss. 11
Closed Access | Times Cited: 164
Potential Applications of NRF2 Inhibitors in Cancer Therapy
Emiliano Panieri, Luciano Saso
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-34
Open Access | Times Cited: 161
NRF2 Activation in Cancer: From DNA to Protein
Erica W. Cloer, Dennis Goldfarb, Travis P. Schrank, et al.
Cancer Research (2019) Vol. 79, Iss. 5, pp. 889-898
Open Access | Times Cited: 157
Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
Zeinab Nouri, Sajad Fakhri, Keyvan Nouri, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2276-2276
Open Access | Times Cited: 155
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
Muhammad Javed Iqbal, Ayesha Kabeer, Zaighum Abbas, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 123
Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications
Tian Liu, Yifei Lv, Jing-Long Zhao, et al.
Free Radical Biology and Medicine (2021) Vol. 168, pp. 129-141
Closed Access | Times Cited: 119
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Saixian Shi, Ye Chen, Zhijian Luo, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 111
Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
Pelin Telkoparan‐Akillilar, Emiliano Panieri, Dilek Cevik, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1417-1417
Open Access | Times Cited: 110
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Ziad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Cell Reports (2022) Vol. 38, Iss. 1, pp. 110190-110190
Open Access | Times Cited: 75
Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
Rana Salam, Alexa Saliou, Franck Bielle, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 75
Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer
Taegeun Bae, Steffanus Pranoto Hallis, Mi‐Kyoung Kwak
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 3, pp. 501-514
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top